1. Home
  2. > Healthcare
  3. > Health Services Market Trends
US Embolization Coils Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, Material, Application, and End User

US Embolization Coils Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, Material, Application, and End User

  • August 2022
  • 147 pages
  • ID: 6321079
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The US embolization coils market is expected to grow from US$ 388.61 million in 2021 to US$ 532.24 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2022 to 2028.

Embolization coils are used to treat brain and cardiac aneurysms and other blood-related conditions.This is used as an alternative to surgical embolization to cut the blood supply to the tumor.

It is used to treat various types of diseases such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, and peripheral vascular diseases.

Market Insights
Rise in Prevalence of Cardiac Aneurysm

Cardiovascular diseases (CVDs) are disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions.Factors such as tobacco use, an unhealthy diet, and physical inactivity increase the risk of heart attacks and strokes.

CVDs are the leading cause of death across the globe, and they affect more people than any other disease.
The cardiac aneurysm is majorly caused due to blockages in the aortic artery.The disease is categorized into two diseases according to the site of blockages.

The blockages in the chest are called thoracic aortic aneurysms, and those in the abdomen are called abdominal aortic aneurysms.There is a rise in the prevalence of cardiac aneurysms worldwide.

For instance, the Society for Vascular Surgery (SVS) stated that every year in the US, 2 million people are diagnosed with an abdominal aortic aneurysm.It also stated that a rupture abdominal aortic aneurysm is the 15th leading cause of death in the country.

It is most commonly seen in people above 55 years of age.

In addition, the abdominal aortic aneurysm is majorly based on family history or inheritance.The immediate relative is more prone to getting an abdominal aortic aneurysm.

They are 10 times more likely to develop an abdominal aortic aneurysm.And the person may have different type of aneurysm.

Therefore, the rise in the prevalence of cardiac aneurysms is fueling the growth of the embolization coils market.
In the US, lung cancer is the leading cause of cancer-related death.Additionally, breast cancer has at least a 25% higher incidence among women and cervical carcinoma is the leading cause of death in 2020.

Moreover, according to the American Cancer Society journal, in 2021, ~1.9 million new cancer cases were diagnosed, and there were ~608,570 cancer deaths in the US. Further, according to National Center for Health Statistics and National Vital System, Mortality Data of the US, in 2020, ~1,153 children younger than 15 years old died of cancer, and 8,863 adolescents and young adults between 15 and 39 years old died of cancer. In addition, 151,578 adults between 40 and 64 years old died of cancer; 338,340 adults between 65 and 84 years old died of cancer; and 102,413 adults who were 85 years and older died of cancer.

Type Insights
Based on type, the US embolization coils market is segmented into detachable coil and pushable coil.In 2021, the detachable coil segment held a larger market share.

Moreover, the same segment is estimated to grow at a significant CAGR of 5.0% during the forecast period. Detachable coils are generally made up of platinum and are used for precisely placing the coils at the desired site of treatment. The detachable coils take less time for the procedure compared to the pushable coils. Detachable coils are characterized as soft or standardized coils used for aneurysms and vessels in various clinical applications. The coils are placed with the one-click mechanical detachment handle technology.

US Embolization Coils Market, by Type – 2022 and 2028

Application Insights
Based on application, the US embolization coils market is segmented into neurology, cardio, urology, oncology, peripheral vascular disease, and other.In 2021, the neurology segment held the largest share of the market.

Moreover, the same segment is expected to grow at the fastest rate in the coming years.The application of the embolization coils in the field of neurology is generally used to treat brain aneurysms and arteriovenous malformations (AVM).

An arteriovenous malformation (AVM) is a tangle of blood vessels connecting arteries and veins that disrupts blood flow and oxygen circulation, resulting in a lack of oxygen for surrounding tissues.
Material Insights
Based on material, the US embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy.The platinum segment held the largest share of the market in 2021.

Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028.
End User Insights
Based on end user, the US embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other.The hospital segment will hold the largest share of the market in 2021.

Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028.

Strategic Insights
Inorganic developments such as mergers and acquisitions are highly adopted strategies by companies in the US embolization coils market. A few of the recent key market developments are listed below:

In August 2022, Boston Scientific Corporation BSX announced the acquisition of Obsidio, Inc. It is a privately held company and the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.

In May 2022, Boston Scientific gained FDA clearance for its Embold Fibered Detachable Coil, a new device developed to assist interventional clinicians with embolization procedures. The Embold Fibered Coil obstructs or reduces blood flow in the patient’s peripheral vasculature.

In August 2022, Boston Scientific Corporation announced that it had received FDA 510(k) clearance for the Embold fibered detachable coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. A full commercial launch of the device will begin in the US in the coming weeks.

Company Profiles
• Terumo Corporation
• Medtronic
• Boston Scientific Corporation
• Stryker
• KANEKA CORPORATION
• MicroPort Scientific Corporation
• Penumbra, Inc
• Cook Medical LLC
• Johnson & Johnson Services, Inc.
• Shape Memory Medical INC,

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Vascular Patches Market by Material, Application, End User - Global Forecast to 2027

  • $ 4950
  • November 2022
  • 133 pages

The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven ...

  • World
  • North America
  • Healthcare
  • Hospital
  • Industry analysis
  • Health Expenditure
  • Hospital Number

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on